Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
McKinsey
Dow
Medtronic
Moodys

Last Updated: June 28, 2022

Carbinoxamine maleate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for carbinoxamine maleate and what is the scope of patent protection?

Carbinoxamine maleate is the generic ingredient in three branded drugs marketed by Mcneil, Cypress Pharm, Mikart, Vintage Pharms, Aytu, Invagen Pharms, Mission Pharmacal Co, Strides Pharma, and Ortho Mcneil Pharm, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Carbinoxamine maleate has twenty-one patent family members in fourteen countries.

There are seven drug master file entries for carbinoxamine maleate. Five suppliers are listed for this compound.

Drug Prices for carbinoxamine maleate

See drug prices for carbinoxamine maleate

Pharmacology for carbinoxamine maleate
Anatomical Therapeutic Chemical (ATC) Classes for carbinoxamine maleate

US Patents and Regulatory Information for carbinoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090435-001 Apr 15, 2010 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mikart CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 040458-001 Apr 25, 2003 RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Vintage Pharms CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 040814-001 Feb 26, 2008 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cypress Pharm CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 090418-001 May 4, 2010 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Cypress Pharm CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090417-001 Aug 23, 2010 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Mikart CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 207484-001 May 31, 2016 RX No Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for carbinoxamine maleate

Country Patent Number Title Estimated Expiration
Japan 2009530298 See Plans and Pricing
South Korea 101495146 See Plans and Pricing
Spain 2378573 See Plans and Pricing
European Patent Office 2428205 Formulations à libération modifiée contenant des complexes médicament - résine échangeuse d'ions (Modified release formulations containing drug-ion exchange resin complexes) See Plans and Pricing
Brazil PI0709606 formulações de liberação modificada contendo complexos fármaco-resina de troca iÈnica See Plans and Pricing
Australia 2007227569 Modified release formulations containing drug-ion exchange resin complexes See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Johnson and Johnson
Dow
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.